Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Nerstrøm

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Association between immunohistochemical expression of vascular endothelial growth factor (VEGF), VEGF-expressing neuroendocrine-differentiated tumor cells, and outcome in prostate cancer patients subjected to watchful waitingM Borre, B Nerstrøm, J Overgaard
Ugeskrift for Laeger|April 21, 1997
[Prostatic cancer: an expensive dilemma]M Borre, B Nerstrøm, J Overgaard
Cancer|November 5, 1997
The natural history of prostate carcinoma based on a Danish population treated with no intent to cureM Borre, B Nerstrøm, J Overgaard
Acta Oncologica (Stockholm, Sweden)|January 1, 1997
The dilemma of prostate cancer--a growing human and economic burden irrespective of treatment strategiesM Borre, B Nerstrøm, J Overgaard
Acta Oncologica (Stockholm, Sweden)|January 1, 1997
Erythrocyte sedimentation rate--a predictor of malignant potential in early prostate cancerM Borre, B Nerstrøm, J Overgaard
Scandinavian Journal of Urology and Nephrology|April 11, 2000
Inflammatory pseudotumour of the bladder: a case reportD P Zubac, S Malmfred, B Nerstrøm
Scandinavian Journal of Urology and Nephrology|January 1, 1975
Urethral pressure profile in prostatic surgeryJ C Djurhuus, R I Hansen, B Nerstrøm
Prostate Cancer and Prostatic Diseases|December 24, 2002
Immunohistochemical BCL-2 and Ki-67 expression predict survival in prostate cancer patients followed expectantlyM Borre, B Stausbøl-Grøn, B Nerstrøm, et al.
The Prostate|August 27, 1998
DNA ploidy and survival of patients with clinically localized prostate cancer treated without intent to cureM Borre, M Høyer, B Nerstrøm, et al.
British Journal of Cancer|October 9, 1998
Microvessel density predicts survival in prostate cancer patients subjected to watchful waitingM Borre, B V Offersen, B Nerstrøm, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Association between immunohistochemical expression of vascular endothelial growth factor (VEGF), VEGF-expressing neuroendocrine-differentiated tumor cells, and outcome in prostate cancer patients subjected to watchful waitingM Borre, B Nerstrøm, J Overgaard
Ugeskrift for Laeger|April 21, 1997
[Prostatic cancer: an expensive dilemma]M Borre, B Nerstrøm, J Overgaard
Cancer|November 5, 1997
The natural history of prostate carcinoma based on a Danish population treated with no intent to cureM Borre, B Nerstrøm, J Overgaard
Acta Oncologica (Stockholm, Sweden)|January 1, 1997
The dilemma of prostate cancer--a growing human and economic burden irrespective of treatment strategiesM Borre, B Nerstrøm, J Overgaard
Acta Oncologica (Stockholm, Sweden)|January 1, 1997
Erythrocyte sedimentation rate--a predictor of malignant potential in early prostate cancerM Borre, B Nerstrøm, J Overgaard
Scandinavian Journal of Urology and Nephrology|April 11, 2000
Inflammatory pseudotumour of the bladder: a case reportD P Zubac, S Malmfred, B Nerstrøm
Scandinavian Journal of Urology and Nephrology|January 1, 1975
Urethral pressure profile in prostatic surgeryJ C Djurhuus, R I Hansen, B Nerstrøm
Prostate Cancer and Prostatic Diseases|December 24, 2002
Immunohistochemical BCL-2 and Ki-67 expression predict survival in prostate cancer patients followed expectantlyM Borre, B Stausbøl-Grøn, B Nerstrøm, et al.
The Prostate|August 27, 1998
DNA ploidy and survival of patients with clinically localized prostate cancer treated without intent to cureM Borre, M Høyer, B Nerstrøm, et al.
British Journal of Cancer|October 9, 1998
Microvessel density predicts survival in prostate cancer patients subjected to watchful waitingM Borre, B V Offersen, B Nerstrøm, et al.
Pageof 3